Cargando…

Correction to: Beyond Response: Aiming for Quality Remission in Depression

Detalles Bibliográficos
Autor principal:	Kennedy, Sidney H.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer Healthcare 2022
Materias:	Correction
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9402718/ https://www.ncbi.nlm.nih.gov/pubmed/35857186 http://dx.doi.org/10.1007/s12325-022-02247-6

Ejemplares similares

Beyond Response: Aiming for Quality Remission in Depression
por: Kennedy, Sidney H.
Publicado: (2022)

Correction to: Treatment adequacy and remission of depression and anxiety disorders and quality of life in primary care older adults
por: Lamoureux‑Lamarche, Catherine, et al.
Publicado: (2021)

Correction to: Metabolic features of recurrent major depressive disorder in remission, and the risk of future recurrence
por: Mocking, Roel J. T., et al.
Publicado: (2021)

Correction to: Psychometric Validation of the Autism Impact Measure (AIM)
por: Houghton, Richard, et al.
Publicado: (2019)

Correction: Prevalence and predictors for sustained remission in rheumatoid arthritis
por: Sung, Yoon-Kyoung, et al.
Publicado: (2019)

quality of remission in the major depressive disorder
por: Chebli, H., et al.
Publicado: (2023)

Correction to: The pulvinar nucleus and antidepressant treatment: dynamic modeling of antidepressant response and remission with ultra-high field functional MRI
por: Kraus, Christoph, et al.
Publicado: (2018)

Correction: Shikonin Suppresses NLRP3 and AIM2 Inflammasomes by Direct Inhibition of Caspase-1
por: Zorman, Jernej, et al.
Publicado: (2016)

Correction: AIM2 Drives Joint Inflammation in a Self-DNA Triggered Model of Chronic Polyarthritis
por: Jakobs, Christopher, et al.
Publicado: (2018)

Correction to: Accelerating evidence gathering and approval of precision medicine therapies: the FDA takes aim at rare mutations
por: Issa, Amalia M., et al.
Publicado: (2018)

Correction to: Response to: “Does ACPA-negative RA consist of subgroups related to sustained DMARD-free remission and serological markers at disease presentation” by Masi and Fleischmann
por: Boeters, Debbie M., et al.
Publicado: (2020)

Aiming beyond equality to reach equity: the promise and challenge of quality improvement
por: Hirschhorn, Lisa R, et al.
Publicado: (2021)

Correction: 2021 DORIS definition of remission in SLE: final recommendations from an international task force
Publicado: (2022)

Correction: Proteinuria changes in kidney disease patients with clinical remission during the COVID-19 pandemic
por: Tsuboi, Nobuo, et al.
Publicado: (2021)

Correction: The Effects of Depression and Anti-Depressants on Quality of Life After Breast Reconstruction: A Post-Hoc Analysis
por: Klifto, Kevin M, et al.
Publicado: (2021)

Correction to: Hepatocellular carcinoma diagnosis using a novel electrochemiluminescence immunoassay targeting serum IgM‑free AIM
por: Shimizu, Tomo, et al.
Publicado: (2022)

Correction: The Cytokine Release Inhibitory Drug CRID3 Targets ASC Oligomerisation in the NLRP3 and AIM2 Inflammasomes
por: Coll, Rebecca C., et al.
Publicado: (2013)

Correction: The Cytokine Release Inhibitory Drug CRID3 Targets ASC Oligomerisation in the NLRP3 and AIM2 Inflammasomes
por: Coll, Rebecca C., et al.
Publicado: (2013)

Correction to: Evaluating the impact of a walking program in a disadvantaged area: using the RE-AIM framework by mixed methods
por: Baba, Camila Tiome, et al.
Publicado: (2017)

Correction: Uncertainty and depressive symptoms as mediators of quality of life in patients with heart failure
por: Chen, Ting-Yu, et al.
Publicado: (2019)

Correction: Stratification and prediction of remission in first-episode psychosis patients: the OPTiMiSE cohort study
por: Martinuzzi, Emanuela, et al.
Publicado: (2019)

Correction: Factors associated with discontinuation of biologics in patients with inflammatory arthritis in remission: data from the BIOBADASER registry
por: Valero, Marta, et al.
Publicado: (2023)

Correction: Fecal calprotectin concentration to assess endoscopic and histologic remission in patients with cancer with immune-mediated diarrhea and colitis
Publicado: (2021)

Correction to: Classical galactosemia: neuropsychological and psychosocial functioning beyond intellectual abilities
por: Welsink-Karssies, Mendy M., et al.
Publicado: (2020)

Correction to: Cystinosis beyond kidneys: gastrointestinal system and muscle involvement
por: Topaloglu, Rezan, et al.
Publicado: (2022)

Correction: Contact Trees: Network Visualization beyond Nodes and Edges
por: Sallaberry, Arnaud, et al.
Publicado: (2016)

Correction to: PML: Regulation and multifaceted function beyond tumor suppression
por: Hsu, Kuo-Sheng, et al.
Publicado: (2018)

Correction to: Beyond the map: evidencing the spatial dimension of health inequalities
por: Fayet, Yohan, et al.
Publicado: (2021)

Correction: Beyond convexity—Contraction and global convergence of gradient descent
Publicado: (2020)

Correction to: Conflict and COVID-19 in Yemen: beyond the humanitarian crisis
por: Alsabri, Mohammed, et al.
Publicado: (2021)

Correction to: Normalization of C-Reactive Protein Predicts Better Outcome in Patients With Crohn's Disease With Mucosal Healing and Deep Remission
por: Lin, Xiaoqing, et al.
Publicado: (2020)

Correction to: Kidney biopsy in lupus nephritis after achieving clinical renal remission: Paving the way for renal outcome assessment
Publicado: (2023)

Author Correction: Perfluoroalkyl substance pollutants activate the innate immune system through the AIM2 inflammasome
por: Wang, Li-Qiu, et al.
Publicado: (2022)

Author Correction: AIM2 inflammasome-derived IL-1β induces postoperative ileus in mice
por: Hupa, Kristof Johannes, et al.
Publicado: (2020)

Correction: Beyond Muscles Stiffness: Importance of State-Estimation to Account for Very Fast Motor Corrections
Publicado: (2014)

Nutritional basis of type 2 diabetes remission
Publicado: (2021)

Correction: The Autism Impact Measure (AIM): Meaningful Change Thresholds and Core Symptom Changes Over One Year from an Online Survey in the U.S.
por: Silkey, Mariabeth, et al.
Publicado: (2022)

Correction: A multicenter retrospective study aiming to identify patients who respond well to adsorptive granulomonocytapheresis in moderately to severely active ulcerative colitis
por: Yamamoto, Takayuki, et al.
Publicado: (2018)

Correction: A multicenter retrospective study aiming to identify patients who respond well to adsorptive granulomonocytapheresis in moderately to severely active ulcerative colitis
por: Yamamoto, Takayuki, et al.
Publicado: (2018)

Treatment-Free Remission—A New Aim in the Treatment of Chronic Myeloid Leukemia
por: Kwaśnik, Paulina, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_5cg4giqf0ogtqb2raa1k0bhu59